
FDA’s Intent To Phase Out Animal Testing Requirement Weighs Down Charles River Stock: Retail’s Disheartened
Read Full Article Shares of Charles River Laboratories International, Inc. (CRL) traded over 3% lower on Friday morning after the U.S. Food and Drug Administration (FDA) announced plans to replace animal testing in the development of monoclonal antibody …